海外の放射性ヨード治療のベスト医師 — ページ2

BKZゾーリンゲン認定がんセンターの主任医師 – ヴィオラ・フォックス博士は、腫瘍疾患に対する革新的な治療を主導しています。

• 化学療法、免疫療法、分子標的療法の専門家
• 2016年より遺伝学の認定専門医
• がん治療のための分子生物学研究に積極的に従事
• ドイツおよびアメリカの腫瘍学会会員

ヴィクトル・アレクサンダー・クロル医師は、マルティヌス病院の消化器内科および内科部門を率いており、高度な診断および治療法を専門としています。

• 豊富な経験を持つ消化器内科・内科部長
• 認定肥満治療センターのディレクター
• 最新の内視鏡および外科手術技術を使用
• 消化器疾患、代謝疾患、心血管疾患の治療における専門家

イスティニエ・リヴ大学病院にて乳がん、肺がん、消化器がんを専門とする。腫瘍学において長年の経験を持つ准教授。

• セルチュク大学医学部で研修
• アンカラ腫瘍クリニックおよびエルズルム地域研修研究病院で勤務
• 2016年に准教授に昇進

放射性ヨウ素治療の広範なトレーニングを受けた内分泌・代謝疾患の専門医。現在、ガズィアンテプ・オゼル・デファ・ライフ病院に勤務。

• アンカラ・ヌムネ教育研究病院で研修
• トルコ内分泌・代謝学会会員
• 複雑な内分泌疾患の管理に精通

腫瘍内科および内科を専門とするアレムダル医師は、メディカルパーク・アンタルヤ病院コンプレックスにおいて、複雑な疾患の治療に豊富な経験を有しています。

• 2006年にコジャエリ大学医学部を卒業
• アクデニズ大学医学部にて腫瘍内科の専門研修を修了
• アクデニズ大学病院およびアンタルヤ教育研究病院に勤務

キム・ヨンソン医師は、内分泌専門医であり、ナウン病院の内分泌科部長を務めています。糖尿病、甲状腺疾患、メタボリックシンドローム、高コレステロール、骨粗鬆症、その他の内分泌疾患の治療を行っています。

ソウル大学校医学部で医学士号を取得。嘉泉大学で内科の大学院研修を修了。その後、サムスン医療センターで内分泌学の臨床フェローとして研修を受けました。

以前はソウル赤十字病院の内科部長を務めていました。また、嘉泉大学ギル医療センターで内分泌・代謝学の教授も務めました。大韓内分泌学会および大韓糖尿病学会の正会員です。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

ヤイール・バー博士は、シェバ医療センターの癌センターの副所長であり、胸部腫瘍内科医です。進行非小細胞肺癌の治療において、個別化免疫療法および標的療法を専門としています。分子生物学の博士号（PhD）を取得しており、免疫療法耐性に焦点を当てた研究室を主導しています。

• イスラエル肺癌グループの議長。
• 腫瘍内科および放射線腫瘍学の専門医認定を取得。
• 世界トップ10にランクされるシェバ医療センターで患者を治療。
• 分子・遺伝子プロファイリングを用いて、精密な癌治療計画を作成。

ウィーン総合病院（AKH）の内分泌外科チームリーダー。甲状腺疾患の専門知識を持ち、内分泌外科を専門とする。

• ウィーン医科大学内分泌外科ワーキンググループ代表
• 甲状腺研究におけるサンドス賞受賞者
• ESESやENETSなど、複数の権威ある学会の会員
• 一般外科および腹部外科の専門医
• 21 年の臨床および学術経験

ムジャヒット・ギュル医師はエムセイ病院で甲状腺疾患を専門とし、個別化された放射性ヨウ素療法を提供しています。

• 内科における_doctor_2971_年以上の経験
• デュズジェ大学医学部で研修
• 糖尿病、高血圧、甲状腺疾患を専門とする

パストラナ医師は、ガレニア病院で放射性ヨウ素治療を専門とする認定外科腫瘍医です。

• 2030年までConacemの認定を取得
• メキシコ腫瘍学会（SMEO）会員
• 2020年よりアナウアック大学で教鞭をとる
• 国立医療センター「20 de Noviembre」で研修

タメル・アタセバー医師は、34 年の核医学の専門知識をメディポル・メガ大学病院にもたらし、放射性ヨウ素治療を専門としています。

• ガジ大学およびアンカラ・オーダー研究所の元教授
• 豊富なリーダーシップ経験を持つ核医学部長
• トルコおよび欧州核医学会会員
• アンカラ大学（核医学の主要プログラム）で研修

放射性ヨウ素治療を専門とし、内科で34 年以上の経験を持ち、現在はMedipol Acibadem病院で勤務しています。

• ガズィアンテプ大学医学部卒業
• Cumhuriyet大学内科で34 年勤務
• 以前はBağcılar Medipol Mega大学病院に勤務
• 現在はMedipol Acibadem病院の専門家チームの一員

エンギン教授は、国立がん研究所やトーマス・ジェファーソン大学での専門的なトレーニングを含む、放射線腫瘍学における数十年の経験を有しています。

• 放射線腫瘍学における_doctor_2595_年以上の経験
• ウルダグ大学放射線腫瘍学科の元学科長
• 米国でのフェローシップ中に温熱放射線療法を専門とする
• Medicana Bursaの腫瘍科学ディレクター

アーマー・アリフ・シェイク医師は、HCGマナヴァタがんセンターにて放射性ヨウ素療法に重点を置き、外科腫瘍学において15 年の専門的経験を有しています。

• 口腔がん治療および臓器温存における専門知識
• 頭頸部外科腫瘍学のフェローシップ修了
• 主要な顎顔面および頭頸部手術に精通
• 多数の論文を発表している研究者

アブドラ・サキン教授（Prof. Dr. Abdullah Sakin）は、腫瘍内科の教授です。肺がん、乳がん、消化器がん、泌尿器がん、婦人科がん、頭頸部がん、悪性黒色腫（メラノーマ）などの固形腫瘍を専門としています。

科学的根拠に基づいた個別化医療を提供しています。治療法には、化学療法、分子標的療法、免疫療法、ホルモン療法、精密腫瘍学（プレシジョン・オンコロジー）が含まれます。200本以上の科学論文を執筆しており、国際的な臨床研究にも積極的に参加しています。これらの活動は、患者中心のがん医療の発展に寄与しています。

ペドロ・ネスプラル・トーレス医師は、マドリードのプブリオ・コルドン記念病院に勤務する核医学専門医です。放射性ヨード内用療法を用いて甲状腺疾患および癌の治療を行っています。トーレス医師は、前立腺癌および膵神経内分泌腫瘍の診療を専門としています。

同医師が勤務する施設は国際医療機能評価機関（JCI）の認証を受けています。当病院には100名以上の専門医が在籍し、欧州の臨床プロトコルに準拠した医療を提供しています。